Over the past decades we have learned that cancer is a very complex disease. There are many forms of cancer arising from organ specific malignancies that can further metastasize to other organs. Tumors themselves are now recognized to not just be one type of cell but a community of many different types of cells, including many types of tumor cells. Key among these cells are what are being called cancer stem cell like cells or CSCs.
Dr. Karunya Kandimalla has been selected as the new associate dean of graduate education for the University of Minnesota College of Pharmacy.
Walters Lab Involved in Collaborative Research Investigating Reference Compounds for Characterizing Cellular Injury
High-throughput screening is a reliable method for discovering compounds that interact with novel therapeutic targets to improve human health. “Nuisance compounds” interfere with drug discovery by confounding screening results.
Mycobacterium abscessus is an opportunistic pathogen that causes severe lung infections, particularly in patients with underlying lung disorders such as cystic fibrosis or chronic pulmonary disease and is intrinsically resistant to most antibiotics. The high pH in the airway lumen environment serves as a natural barrier, in
Recognizes connections to Minnesota and College of Pharmacy as influential
Honor bestowed on behalf of the advancement of science or its applications that are scientifically or socially distinguished.
NCPDP Foundation Awards Research Grant to College to Evaluate the NCPDP/HL7 Specialty Medication Enrollment Standard
The NCPDP Foundation Board of Trustees announced it has awarded a $102,300 research grant to the University of Minnesota College of Pharmacy to evaluate the quality of data obtained from EHRs using the NCPDP/HL7 Specialty Medication Enrollment Standard.
Dr. Keri Hager, co-associate dean for clinical affairs, Department of Pharmacy Practice and Pharmaceutical Sciences, has been selected as an inductee into the Academy for Excellence in Clinical Practice.
U of M Institute for Therapeutics Discovery and Development (ITDD) selected for participation in a national Chemical Biology Consortium
The CBC is a highly collaborative national drug discovery consortium designed to integrate all aspects of early-stage drug discovery.
Drs. Gunda Georg and Vadim Gurvich will co-lead the contract.